Clozapine is the medication of choice for those with treatment-resistant schizophrenia. Clozapine is also FDA approved for the reduction in suicidal behavior in schizophrenia or schizoaffective disorder and effective for treatment-resistant mood disorders. Despite the clinical benefits of clozapine, hesitancy to prescribe the medication is not uncommon based on perceived dangers and rigorous monitoring parameters.
The professional affairs committee is maintaining a set of presentation slides to help you introduce more people to psychiatric pharmacy.
AAPP is pleased to provide a suggested reading list as a service and as a forum for member discussion. If you shop with AAPP by following the links below to Amazon, a small commission will be paid to AAPP which helps to financially support our mission to improve the minds and lives of individuals with psychiatric disorders.
Dr. Seth Gomez is a psychiatric pharmacist working for Alameda County Behavioral Health Care Services. Find out how his work supporting primary care physicians in providing Medication for Opioid Use Disorder Treatment (MOUD) services has brought patient care to another level.
Dr. Bridget Bradley teaches at Pacific University School of Pharmacy and practices as a pharmacist at one of Virginia Garcia Memorial Health Center’s primary care clinics in Hillsboro, Oregon. Learn how Dr. Bradley, as the only psychiatric pharmacist within the health center’s five clinics, is essential to the success of the entire mental health team.
Dr. Dana Chiulli is a psychiatric pharmacist at the Ralph H. Johnson Veterans Affairs (VA) Outpatient Clinic in Savannah, Georgia, a satellite of the VA Hospital in Charleston, South Carolina. Learn how Dr. Chiulli improves access to care for Veterans with a wide variety of locations and needs.
Dr. Jeffrey Gold is a psychiatric pharmacist and the psychiatric pharmacy residency director at the Veterans Affairs (VA) Rocky Mountain Regional Medical Center in Denver, Colorado. Find out how he has become an integral part of the treatment team and extended its reach via telehealth.
Dr. Rosana Steavenson is a psychiatric pharmacist and the program manager of the Mental Health Clinical Pharmacy Program at the South Texas Veterans Affairs (VA) Health Care System. Learn how Dr. Steavenson impacts treatment at her practice site and throughout the country.
The existance of the CPNP Foundation is a direct reflection of the selfless dedication of you as CPNP members. Thank you so much to everyone who contributed to our $40,000 year-end fundraising goal! We are thrilled to continue this important, ongoing work. Donate Now and Make Your Pledge for 2020.
No summary available
No summary available
Membership in AAPP brings numerous benefits as listed below. This member toolkit provides you a convenient location to explore information and benefits associated with a AAPP membership.
Psychiatric pharmacists work directly with patients and caregivers to apply specialized clinical knowledge and skills, educate and train healthcare professionals and develop new knowledge in order to improve health outcomes for those individuals with psychiatric disorders, including substance use and neurologic disorders. They apply evidence-based, cost-efficient best practices as a member of a treatment team to achieve patient recovery and improved quality of life.
Shannon Eaves Stratton, PharmD, BCPS, BCPP Mental Health Clinical Pharmacy Practitioner Richard L. Roudebush VA Medical Center Indianapolis, IN
AAPP 2025 industry supported symposia (continuing education) and showcases (non-continuing education) are programs developed for educational purposes. All industry-supported programming at AAPP 2025 is designed for the psychiatric pharmacist and is included in participant registration fees. All symposia are in compliance with Accreditation Council for Pharmacy Education (ACPE) criteria for planning and implementation, and each one provides 1.0 contact hours of ACPE credit.
October 2-3, 2025 You are invited to join us for the 5th Annual Summit! The Summit is designed to advance the knowledge and improve competency of participants through the delivery of evidence-based presentations on emerging areas of practice and contemporary issues in psychiatric pharmacy. This two-day, interactive, virtual conference provides knowledge and tools to improve the comprehensive care of patients with mental health disorders.
The American Association of Psychiatric Pharmacists (AAPP) promotes the utilization of evidence-based resources during the development of content for presentations, toolkits, manuscripts, etc. AAPP strives to disseminate information that is fair and balanced, grounded in sound scientific evidence, and aligned with established best practices to support safe, effective patient care.